Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessing the Value of a Dosage of Anti-cetuximab in the Therapeutic Management of Patients With Colon Cancer or Upper Aero-digestive Tract and Candidates for Treatment With Cetuximab (IgES)

This study has been completed.
University Hospital, Caen
Information provided by (Responsible Party):
Centre Francois Baclesse Identifier:
First received: September 14, 2011
Last updated: March 7, 2013
Last verified: March 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2013
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)